nabi share buy back, page-13

"come to the conclusion that the proposed merger "is not in the best interest of shareholders and deeply undervalues" the company."


deeply undervalues Nabi? What will Nabi contribute to the new Company besides the U$54m cash and potential royalty stream from PhosLyra? Nothing more!

At around 80cents per Biota share, Nabi's cash is deeply undervalued?

We all know that Biota currently has U$231m BARDA contract for Lani ROW.

So, the above hedge fund's statement is ridiculous from the point of a genuine Nabi shareholder, IMO.

However, those institutional shorters would like all the companies their have shorted on go into liquidation and the liquidation processes last forever so that they do not have to return their shares (proceeds returned to genuine shareholders after liquidation) forever.


Just my thoughts.